of He is the first Canadian to serve as vice chair on the board of a global type 1 diabetes non-profit organization.
, /PRNewswire/ — JDRF, the world’s leading type 1 diabetes (T1D) research and advocacy organization, today announced the following appointments: He has been sworn in as the new vice chair of the nonprofit’s international board of directors.Matt’s is the first Canadian and the first foreign-born person. Maintain the position of Vice-Chairman. He is a senior executive at Royal Bank. the nation’s largest financial institution, where he is responsible for more than 4,500 financial institutions. Base employees who manage personal investments, mortgage lending, and group benefits over and above the total amount. Every year.
“These are exciting times for JDRF, filled with scientific advances and real opportunities to advance our mission of creating a world without type 1 diabetes.” , Ph.D., JDRF CEO. “I am delighted that Matt will be taking on the role of Vice Chair of JDRF’s International Board of Directors. I look forward to his partnership as we expand JDRF’s work around the world.”
Matt has been an active JDRF volunteer since 2001 and is a passionate supporter of JDRF’s efforts to find a cure for T1D and improve the lives of people living with T1D. In addition to serving on JDRF’s International Board of Directors, Matt also serves on his JDRF Canada Board of Directors.
“I have been a volunteer with JDRF for over 20 years and am honored to take on the role of Vice Chair of JDRF’s International Board of Directors,” he said. . “I’m excited to work with people around the world to advance JDRF’s great purpose and accelerate life-changing breakthroughs and treatments for type 1 diabetes.”
Matt and his wife Dr. , are the parents of four adult children.he is a graduate in Ontario.
Mr. Varey begins his next term as leader of the Board. lisa fishbone wallach, has been appointed as the new Chair of JDRF’s International Board of Directors. Lisa is a trained lawyer; area.
About JDRF
JDRF’s mission is to accelerate life-changing breakthroughs to treat, prevent, and cure type 1 diabetes (T1D) and its complications. To achieve this, JDRF has invested in: We have been funding research since our founding. We believe in connecting people in local communities, collaborating locally and globally for efficiency and broader funding impact, and coming together on the global stage to share resources, passion and energy. We are an organization built on a grassroots model. We collaborate with academic institutions, policy makers, corporate and industry partners to develop and deliver a pipeline of innovative treatments to people living with T1D. Our staff and volunteers are Our five international affiliates are dedicated to advocacy, community engagement, and our vision of a world without T1D. For more information, visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq).
About type 1 diabetes (T1D)
T1D is an autoimmune disease in which the pancreas produces little or no insulin. This leads to dependence on insulin therapy and the risk of short- and long-term complications, including high and low blood sugar levels. Damage to the kidneys, eyes, nerves, and heart. Without treatment, it can even lead to death. It affects approximately 9 million people worldwide. Although many people believe that T1D is only diagnosed in childhood and adolescence, diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The development of T1D has nothing to do with diet or lifestyle. Its causes are not yet fully understood, but scientists believe that both genetic and environmental factors are involved. There is currently no cure for T1D.
JDRF International Media Contact:
Chelsea-Lynn Rudder
646-946-0513
JDRF Canada Media Contact:
Ruth Capellas
647.789.2322
Source JDRF